Milestone Scientific, Inc. MLSS
0.41
0.00
0.00%
as of 25 Sep
- Market cap
- $37.2M
- P/E
- 0.0×
Follow MLSS
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (121.68%) | (135.39%) | (132.38%) | (136.47%) |
+8 more TTM periods Free account |
|
| (50.54%) | (53.58%) | (65.01%) | (67.82%) | ||
ROIC |
(136.16%) | (148.05%) | (140.88%) | (204.19%) | |
Return on Tangible Assets |
(110.80%) | (181.72%) | (170.02%) | (215.43%) | |
Average Days of Receivables |
40.80 | 23.70 | 28.72 | 29.29 | |
Free Cash Flow per Share |
(0.01) | (0.02) | (0.04) | (0.05) | |
Free Cash Flow |
(0.66) | (1.84) | (2.93) | (4.22) | |
Capital Expenditures |
(0.02) | (0.02) | (0.02) | (0.02) | |
Piotroski F-Score |
4.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(10.68%) | (42.37%) | (61.37%) | (88.86%) | |
Accounts Receivable Turnover |
10.81 | 16.14 | 15.19 | 14.06 | |
Accounts Payable Turnover |
1.16 | 0.87 | 1.19 | 1.02 | |
Inventory Turnover |
0.80 | 0.67 | 0.68 | 0.64 | |
Average Days of Payables |
372.43 | 461.62 | 396.79 | 441.64 | |
Days of Inventory on Hand |
401.73 | 494.07 | 537.86 | 599.52 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.92% | 0.00% | 5.01% | 7.33% | |
Selling, General and Administrative Expense of Revenue |
112.59% | 120.09% | 129.00% | 138.35% | |
Share Based Compensation of Revenue |
17.08% | 15.38% | 18.74% | 17.77% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.16 | 0.40 | 0.51 | 0.63 | |
Depreciation/Fixed assets |
9.27 | 10.18 | 9.67 | 9.25 | |
Capex/Depreciation |
(0.08) | (0.08) | (0.08) | (0.09) | |
Revenue per Share |
0.10 | 0.10 | 0.11 | 0.11 | |
Operating CF per Share |
(0.01) | (0.02) | (0.04) | (0.05) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(43.98%) | (51.30%) | (63.77%) | (74.66%) |
Columns are period end dates